News

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...
Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...
Lepore starts Aug. 18 at Air Products, which has 23,000 employees spread across 50 countries and ranks 347th in the Fortune ...
Nationwide employment law firm Jackson Lewis PC has added Kaha Kvachatadze as a principal in its White Plains office. He ...
Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...
Severance plans subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) must satisfy certain compliance requirements, ...
Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...
Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...
The Trump administration is asking the Supreme Court to allow it to cut hundreds of millions of dollars’ worth of research ...
A Texas man is suing a California doctor for allegedly providing his girlfriend with abortion medication. The lawsuit—a civil ...
The Canadian Patent Office has a procedure for the “re-examination” of a granted patent. However, this procedure is rarely used in Canada for several reasons. Less than half a dozen re-examinations ...